Evidence map›Paper›PMID 37884904›Full record

ArticleBMC nephrology2023

Paeoniflorin alleviates hypoxia/reoxygenation injury in HK-2 cells by inhibiting apoptosis and repressing oxidative damage via Keap1/Nrf2/HO-1 pathway.

Di Xing, Yihua Ma, Miaomiao Lu, Wenlin Liu, Hongli Zhou

Open access · goldAbstract read
In one paragraph

Article in BMC nephrology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. METTL3-driven mFrontiers in immunology · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Retinal Ischemia: Therapeutic Effects and Mechanisms of Paeoniflorin.International journal of molecular sciences · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Di Xing *Department of Nephrology, The First Affiliated Hospital of Jinzhou Medical University, Liaoning, China.
Yihua Ma *Department of Traditional Chinese Medicine, The First Affiliated Hospital of Jinzhou Medical University, Liaoning, China.
Miaomiao LuDepartment of Nephrology, The First Affiliated Hospital of Jinzhou Medical University, Liaoning, China.
Wenlin LiuDepartment of Nephrology, The First Affiliated Hospital of Jinzhou Medical University, Liaoning, China.
Hongli ZhouDepartment of Nephrology, The First Affiliated Hospital of Jinzhou Medical University, Liaoning, China. 26675204@qq.com.
Jinzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute kidney injury (AKI) is a serious disorder associated with significant morbidity and mortality. AKI and ischemia/reperfusion (hypoxia/reoxygenation, H/R) injury can be induced due to several reasons. Paeoniflorin (PF) is a traditional herbal medicine derived from Paeonia lactiflora Pall. It exerts diverse therapeutic effects, including anti-inflammatory, antioxidative, antiapoptotic, and immunomodulatory properties; thus, it is considered valuable for treating several diseases. However, the effects of PF on H/R injury-induced AKI remain unknown. In this study, we established an in vitro H/R model using COCL

Indexed as

Acute Kidney InjuryReperfusion InjuryApoptosisGlycosidesHumansHypoxiaKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Oxidative StressReactive Oxygen SpeciesSignal TransductionSuperoxide DismutaseGlycosidesKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2peoniflorinReactive Oxygen SpeciesSuperoxide DismutaseHypoxia/Reoxygenation InjuryNrf2/HO-1 pathwayOxidative stressPaeoniflorin

Identifiers

PMID37884904
PMCPMC10601317
OpenAlexW4387958081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.